. "NCT00575055" . "klinisch onderzoek"@nl . . . . . . "88"^^ . . . . . "Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)"@en . . . . . . . . . . . . . . . . . . . . . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "1121"^^ . . . "Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)"@en . . . . . . . . . . . . . "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) In Patients With Mild to Moderate Alzheimer's Disease Who Are Apolipoprotein E4 Carriers."@en . "2012-04-01T00:00:00Z"^^ . . . . . . . . . . . . . . . . . . . . . "clinical trial"@en . "2007-12-01T00:00:00Z"^^ . . . "50"^^ . . . . "Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)"@en . . . . . "ensayu cl\u00EDnicu"@ast . .